This week, the House will vote on a continuing resolution to fund government programs through the end of fiscal year 2025 (FY25).
This includes funding for the Department of Defense’s Congressionally Directed Medical Research Program (CDMRP), which has provided millions of dollars of research funding for ME/CFS and Long Covid research.
Unfortunately, the proposed legislation cuts FY25 funding for the CDMRP from $1.509 billion to $650 million — a 57 % cut from the FY24 enacted level.
This is not a “clean” continuing resolution. Cuts of this magnitude, particularly as they come when we are already six months into the fiscal year, would significantly disrupt research into new therapeutics for diseases and disorders that impact to members of the Armed Services, as well as veterans, military families, and the general public.
Each year, Solve specifically advocates for ME/CFS to continue to be included in the Department of Defense (DoD) Congressionally Directed Medical Research Programs (CDMRP). Thanks in part to Solve’s ongoing advocacy efforts, ME/CFS has been included in the CDMRP program since FY2019. In 2024, this innovative, competitive program provided research funding to 42 congressionally selected diseases including ME/CFS.
We simply can’t afford to lose this crucial funding now.
Tell your Congressional representative to negotiate for full funding for the CDMRP!
Click here to take action now.
